Organon & Co. (NYSE:OGN) Q4 2023 Earnings Call Transcript February 15, 2024 Organon & Co. beats earnings expectations. Reported EPS is $0.88, expectations were $0.8. Organon & Co. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Thank you for standing […]
Eli Lilly said on Friday its
drug Emgality did not meet the primary goal of superiority to
Pfizer Inc s Nurtec ODT in prevention of episodic
migraine in a post-approval study. This was. | June 16, 2023
Eli Lilly must pay Teva Pharmaceuticals International $176.5 million after a trial to determine whether its migraine drug Emgality infringed three Teva patents, a Boston federal court jury decided on Wednesday.
Eli Lilly ordered to pay $176.5 million to Teva in U.S. migraine drug patent trial streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.